日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cost-Effectiveness of Once Weekly Rezafungin for the Treatment of Invasive Candidiasis in the United Kingdom

在英国,每周一次使用瑞扎芬净治疗侵袭性念珠菌病的成本效益分析

Muszbek, Noemi; Angdembe, Alisha; Garcia-Vidal, Carolina; Bielicka, Inga; Abrams, Keith R; Tolley, Keith; Ruhnke, Markus; Lebmeier, Maximilian; Hawkins, Neil; Manamley, Nick; Dickerson, Sara

Protective Effect of Factor XIII Intron-K G Allele on Subclinical Vascular Disease

因子XIII内含子-K G等位基因对亚临床血管疾病的保护作用

Cogoi, Barbara; Esze, Regina; Somodi, Sándor; Shemirani, Amir H; Bereczky, Zsuzsanna; Muszbek, László; Paragh, György; Katkó, Mónika; Káplár, Miklós

Exploring factor XIII genetic diversity: a familial approach to inheritance and variation

探索因子 XIII 的遗传多样性:一种基于家族的遗传和变异研究方法

Naz, Arshi; Zameer, Sana; Rind, Hyder Ali Pehilwani; Khan, Tehmina Nafees Sonia; Siddiqi, Younus Jamal; Shaikh, Abdul Rehman Khalil; Memon, Shahida; Ujjan, Ikram Din; Katona, Eva; Muszbek, László

Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care

英国蕈样肉芽肿或塞扎里综合征皮肤T细胞淋巴瘤患者的总体生存率:莫加莫单抗与当前标准疗法的疗效比较

Hawkins, Neil; Muszbek, Noemi; Evans, Rachel; McNamara, Linda; Jones, Trefor

Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma

莫加莫单抗治疗晚期蕈样肉芽肿和塞扎里综合征皮肤T细胞淋巴瘤的成本效益分析

Muszbek, Noemi; Remak, Edit; Xin, Qian; McNamara, Linda; Jones, Trefor

Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles

激活机制依赖细胞因子 XIII 在活化血小板和血小板微粒上的表面暴露

Laura Somodi, Ildikó Beke Debreceni, Gréta Kis, Marco Cozzolino, János Kappelmayer, Miklós Antal, György Panyi, Helga Bárdos, Nicola J Mutch, László Muszbek

Effect of α2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism

α2-纤溶酶抑制剂异质性对静脉血栓栓塞风险的影响

Barbara Baráth, Réka Bogáti, Tünde Miklós, Judit Kállai, Zoltán A Mezei, Zsuzsanna Bereczky, László Muszbek, Éva Katona

The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations

因子 XIII-A Val34Leu 多态性在高纤维蛋白原浓度下降低全血凝块质量

Sravya Kattula, Zsuzsa Bagoly, Noémi Klára Tóth, László Muszbek, Alisa S Wolberg

Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment

终末期肾病患者接受血液透析滤过或血液透析治疗时凝血级联反应的末端阶段成分

Pénzes, Krisztina; Hurják, Boglárka; Katona, Éva; Becs, Gergely; Balla, József; Muszbek, László

Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes

细胞因子 XIII,人角膜角质细胞中的一种转谷氨酰胺酶

Orosz, Zsuzsanna Z; Bárdos, Helga; Shemirani, Amir H; Beke Debreceni, Ildikó; Lassila, Riitta; Riikonen, Antti S; Kremer Hovinga, Johanna A; Seiler, Theo G; van Dorland, Hendrika A; Schroeder, Verena; Boda, Zoltán; Nemes, László; Früh Eppstein, Beatrice; Nagy, Bence; Facskó, Andrea; Kappelmayer, János; Muszbek, László